You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TNYA Sale Disclosure
Ali Faraz · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$5.26K
Ali Faraz Chief Executive Officer
TNYA
Tenaya Therapeutics
TNYA
Transaction date
Aug 17, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed same day
TNYA daily price context
Close on/before transaction
$0.7
Aug 17, 2026
First close after public filing
$0.7
Aug 18, 2026
30-day return after filing
-5.84%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,406 shares @ $0.71
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-354518
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$15.78K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tenaya Therapeutics, Inc. TNYA | Sale | Aug 17, 2026 | $3.56K |
| Tenaya Therapeutics, Inc. TNYA Current | Sale | Aug 17, 2026 | $5.26K |
| Tenaya Therapeutics, Inc. TNYA | Sale | Aug 17, 2026 | $4.14K |
| Tenaya Therapeutics, Inc. TNYA | Sale | Aug 17, 2026 | $2.82K |